Log In
Print this Print this

RX-10001 (formerly RvE1)

  Manage Alerts
Collapse Summary General Information
Company Resolvyx Pharmaceuticals Inc.
DescriptionSmall molecule resolvin derived from the oxidation of the omega-3 fatty acid eicosapentaenoic acid (EPA)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today